Research Funding Opportunity: RFA-HD-25-002: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions

The National Institute of Health (NIH) recently released a Request for Applications (RFA) for research in Fragile X syndrome (FXS) and FMR1-associated conditions.  An RFA is a type of notice in which an organization announces that grant funding is available.  A grant is a financial award given by the federal, state, or local government for the benefit of research.

In June 2024, NIH published RFA-HD-25-002: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions.  If you or someone you know are researching FXS and/or FMR1-associated conditions, this could be a great funding opportunity for you!

If you are interested in applying for this grant, here are some helpful links to learn more:

• Informational Pre-Submission Webinar – RFA-HD-25-002: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions
• Frequently Asked Questions (FAQs) – Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions
• Read through the entire RFA and apply here
• Learn about the Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (“Fragile X Centers”) Program here

 Important dates:

• RFA posted date:  June 7, 2024
• Letter of Intent due date:  July 6, 2024
• Earliest submission date:  July 6, 2024
• Final submission date:  August 20, 2024

If you have any questions, you should contact the following staff from the participating NIH institutes to discuss how your proposal will align with the goals and requirements of this RFA: